{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-267387","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2021-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.067076+00:00","generated_at":"2026-06-29T05:22:03.673894+00:00","sec_items":["1.01","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ICU Medical to acquire Smiths Medical for $2.35B in cash and stock; expected close H1 2022","bullets":["Total consideration: $1.85B cash, 2.5M ICUI shares (~$500M), plus up to $100M earn-out based on stock price.","Combination creates ~$2.5B pro forma revenue infusion therapy company; Smiths to own ~10% of ICUI post-close.","Smiths gains board seat if it holds ≥5% of ICUI; shares subject to 6-month lock-up and standstill restrictions.","Transaction subject to antitrust, FDI approvals, and Smiths' French works council consultation; long-stop date undefined.","$2B senior secured credit facilities committed by Wells Fargo and Barclays to fund cash portion."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-267387","json":"https://secwatch.observer/filing/0001193125-21-267387.json","markdown":"https://secwatch.observer/filing/0001193125-21-267387.md","text":"https://secwatch.observer/filing/0001193125-21-267387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000119312521267387/0001193125-21-267387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000119312521267387/d228927d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:22:03.673894+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}